A genetically modified tumor-infiltrating lymphocytes product (GT202) exhibits enhanced persistence and anti-tumor efficacy against solid tumor in vivo

被引：0
|
作者：
Sun, Jingwei [1 ]
Jin, Jiahui [1 ]
Tan, Yongchao [1 ]
Chen, Lingyun [1 ]
Wang, Quanwei [1 ]
Liu, Yarong [1 ]
机构：
[1] Grit Biotechnol, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5581
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A genetically modified tumor-infiltrating lymphocytes product (GT216) enhanced anti-tumor efficacy against solid tumor by fine-tuning multiple negative immune regulators
    Sun, Jingwei
    Tan, Yiyang
    Jin, Jiahui
    Wang, Jingman
    Chen, Lingyun
    Guo, Fengbiao
    Tan, Yongchao
    Xu, Zhao
    Liu, Yarong
    CANCER RESEARCH, 2024, 84 (06)
  • [2] A Functionally Enhanced Tumor-Infiltrating Lymphocytes Product (GT201) Exhibits Improved Persistence and Anti-Tumor Efficacy with Low IL-2 Dependency
    Sun, Jingwei
    Jin, Jiahui
    Wang, Quanwei
    Tan, Yiyang
    Wang, Pin
    Wang, Jingman
    Tan, Yongchao
    Xu, Zhao
    Chen, Lingyun
    Liu, Yarong
    MOLECULAR THERAPY, 2023, 31 (04) : 556 - 556
  • [3] GENETICALLY ENGINEERED TUMOR-INFILTRATING LYMPHOCYTES (CYTOTIL15) EXHIBIT IL-2-INDEPENDENT PERSISTENCE AND ANTI-TUMOR EFFICACY AGAINST MELANOMA IN VIVO
    Burga, Rachel
    Khattar, Mithun
    Lajoie, Scott
    Pedro, Kyle
    Foley, Colleen
    Ocando, Alonso Villasmil
    Tremblay, Jack
    Primack, Benjamin
    Langley, Meghan
    Thornton, Dan
    Tam, Stanley
    Brideau, Emily
    Ross, Theresa
    Wilmes, Gwen
    Saha, Sunandan
    Helmlinger, Gabriel
    Tchaicha, Jeremy
    Sethi, Dhruv
    Ols, Michelle
    Vanasse, Gary
    Subramanian, Shyam
    ter Meulen, Jan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A176 - A176
  • [4] A VEGFR2–MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice
    Yao Xu
    Xinrong Zhang
    Yong Wang
    Mingzhu Pan
    Min Wang
    Juan Zhang
    Cancer Immunology, Immunotherapy, 2019, 68 : 1429 - 1441
  • [5] A VEGFR2-MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice
    Xu, Yao
    Zhang, Xinrong
    Wang, Yong
    Pan, Mingzhu
    Wang, Min
    Zhang, Juan
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (09) : 1429 - 1441
  • [6] Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytes in vivo and in vitro
    Wang, Wen-Chao
    Zhang, Zong-Qin
    Li, Peng-Peng
    Ma, Jun-Yong
    Chen, Lei
    Qian, Hai-Hua
    Shi, Le-Hua
    Yin, Zheng-Feng
    Sun, Bin
    Zhang, Xiao-Feng
    CANCER BIOLOGY & THERAPY, 2019, 20 (09) : 1187 - 1194
  • [7] GENETICALLY MODIFIED TUMOR-INFILTRATING LYMPHOCYTES FOR CANCER-THERAPY
    FRIEDMANN, T
    CANCER CELLS-A MONTHLY REVIEW, 1991, 3 (07): : 271 - 274
  • [8] Engraftment of human tumor-infiltrating lymphocytes and the production of anti-tumor antibodies in SCID mice
    Williams, SS
    Chen, FA
    Kida, H
    Yokota, S
    Miya, K
    Kato, M
    Barcos, MP
    Wang, HQ
    Alosco, T
    Umemoto, T
    Croy, BA
    Repasky, EA
    Bankert, RB
    JOURNAL OF IMMUNOLOGY, 1996, 156 (05): : 1908 - 1915
  • [9] Tet2 inactivation enhances the anti-tumor efficiency of tumor-infiltrating lymphocytes (TILs).
    Lee, Minjung
    Li, Jiangfang
    Fang, Shaohai
    Han, Wei
    Moczygemba, Margarita
    Zhou, Yubin
    Li, Jia
    Sun, Deqiang
    Huang, Yun
    CANCER RESEARCH, 2020, 80 (23)
  • [10] Assessment of the presence and anti-tumor potential of tumor-infiltrating lymphocytes in patients with acute myeloid leukemia
    Wei, Liya
    Wang, Zhenkun
    Zhang, Zhuo
    Li, Yinghua
    Fan, Shengjin
    Zhao, Yanqiu
    Liu, Zhiyu
    Ye, Xiangmei
    Zhang, Fan
    Yu, Yingying
    Liu, Xiaolong
    Cao, Fenglin
    Zhou, Jin
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3187 - 3196
12345